Kumar Harsh, Kumar Davinder, Kumar Pradeep, Thareja Suresh, Marwaha Minakshi Gupta, Navik Umashanker, Marwaha Rakesh Kumar
Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, Haryana, India.
Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda, 151401, Punjab, India.
BMC Chem. 2022 Sep 15;16(1):68. doi: 10.1186/s13065-022-00861-7.
A novel series of thiazolidine-2,4-dione molecules was derived and their chemical structures were established using physiochemical parameters and spectral techniques (H-NMR, IR, MS etc.). The synthesized molecule were then evaluated for their antioxidant, anticancer and antimicrobial potential.
Serial tube dilution method was employed to evaluate the antimicrobial potential against selected fungal and bacterial strains by taking fluconazole and cefadroxil as reference antifungal and antibacterial drugs respectively. 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging activity was used to assess the antioxidant potential of the synthesized analogues. Further, the anticancer potential of the selected molecules was assessed against DU-145 cancer cell lines using MTT assay. The drug-likeness was also evaluated by studying in-silico ADME parameters of the synthesized analogues.
In antioxidant evaluation studies, the analogue H5 with IC = 14.85 μg/mL was found to be the most active molecule. The antimicrobial evaluation outcomes suggested that the molecules H5, H13, H15 and H18 possessed moderate to promising activity against the selected species of microbial strains having MIC range 7.3 µM to 26.3 µM. The results of anticancer evaluation revealed that all the screened derivatives possess mild anticancer potential. The in-silico ADME studies revealed that all the compounds were found to be drug-like.
衍生出了一系列新型噻唑烷-2,4-二酮分子,并利用物理化学参数和光谱技术(氢核磁共振、红外光谱、质谱等)确定了它们的化学结构。然后对合成的分子进行抗氧化、抗癌和抗菌潜力评估。
采用系列试管稀释法,分别以氟康唑和头孢羟氨苄作为参考抗真菌和抗菌药物,评估对所选真菌和细菌菌株的抗菌潜力。利用2,2-二苯基-1-苦基肼(DPPH)自由基清除活性来评估合成类似物的抗氧化潜力。此外,使用MTT法评估所选分子对DU-145癌细胞系的抗癌潜力。还通过研究合成类似物的计算机模拟ADME参数来评估药物相似性。
在抗氧化评估研究中,发现IC50 = 14.85 μg/mL的类似物H5是活性最强的分子。抗菌评估结果表明,分子H5、H13、H15和H18对所选微生物菌株具有中度至良好的活性,MIC范围为7.3 μM至26.3 μM。抗癌评估结果显示,所有筛选出的衍生物都具有轻度抗癌潜力。计算机模拟ADME研究表明,所有化合物都具有药物相似性。